(Q83737803)
Statements
Phase I trials of molecularly targeted agents: should we pay more attention to late toxicities? (English)
Sophie Postel-Vinay
Carlos Gomez-Roca
L Rhoda Molife
Bhavesh Anghan
Antonin Levy
Ian Judson
Jean-Charles Soria
Stan Kaye
Xavier Paoletti